UK study finds SARS-CoV-2 antibodies in domestic cats and dogs

Researchers analyzed sera from pet cats and dogs and found them to have developed antibodies against the virus later on during the coronavirus disease 2019 (COVID-19) pandemic. These findings suggest that viral prevalence among the human populations could have led to the pets becoming infected.

Although it mainly affects humans, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can also infect animals. It is important to be aware of such infections, especially in pets, where there is close contact with humans.

There have now been several reports of the virus in cats and dogs in many parts of the world, including France, Germany, China, and the United Kingdom. Studies suggest cats are susceptible to the virus and can transmit it to other cats. Generally, infection in pets seems to come from human-to-animal transmission.

Study: SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom. Image Credit: Tik.tak / Shutterstock

There are also reports of transmission of SARS-CoV-2 from animals to humans, for example, from farmed minks, cats, and dogs. Hence, it is important to maintain close surveillance of SARS-CoV-2 in pets.

In new research, a team of scientists surveyed SARS-CoV-2 neutralizing antibodies in cats and dogs visiting vets in the United Kingdom. They have recently released their preliminary data on the bioRxiv* preprint server, while their article undergoes peer review.

Positive later in the pandemic

The team obtained dog and cat sera from the UK Virtual Biobank, which uses leftover diagnostic samples for genomic analysis. Sera used in the study were collected between March and April 2020, September 2020 to February 2021, and January 2021. SARS-CoV-2 neutralizing antibodies were tested using the plaque reduction neutralization test.

The authors tested a total of 688 sera; 558 were obtained during the COVID-19 pandemic, and 130 were samples collected before the pandemic. None of the sera collected in March and April 2020 had SARS-CoV-2 neutralizing antibodies, while 1.4% of the dog sera collected between September 2020 and February 2021 had them, and 2.2% of the cat sera collected in January 2021 were positive. The positive dog samples were collected in November 2020, January 2021, and February 2021. The positive cat samples were collected in January 2021.

Thus, sera collected early in the pandemic were negative for neutralizing antibodies. Other studies on samples collected in Europe showed a low level of infection in cats and dogs, with a highest of 3.3% of dog sera and 5.8% of cat sera testing positive in Italy during early 2020. The samples were collected from Italian regions with a high proportion of cases.

Sera collected later in the pandemic in the UK showed a prevalence of neutralizing antibodies in cats and dogs. This is similar to what was also seen in a German survey later in the pandemic. With an increase in cases in humans, there was an increase in virus transmission to their pets.

Continuing to monitor animals

Cats and dogs can also be infected with other coronaviruses, and it is possible that the observed neutralizing antibodies were because of a previous infection. However, studies have shown there is no cross-reactivity between SARS-CoV-2 antibodies and feline and canine coronaviruses, which are usually present in cats and dogs in the UK. In addition, there were no SARS-CoV-2 antibodies in samples collected before the pandemic, suggesting cat and dog coronavirus infections do not cross-react with SARS-CoV-2.

The authors write:

The small numbers of companion animals testing positive in the field suggest that pets are not currently acting as a significant reservoir for infection, and that the pandemic will be controlled by measures largely focussed on minimizing human-to-human transmission.”

However, they also write that continued surveillance of animals in contact with humans to determine if control measures are needed in the future for pet animals.

*Important notice

bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
  • Smith, S. et al. (2021) SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom. bioRxiv,

Posted in: Medical Science News | Medical Research News | Miscellaneous News | Disease/Infection News | Healthcare News

Tags: Antibodies, Coronavirus, Coronavirus Disease COVID-19, Diagnostic, Genomic, Pandemic, Research, Respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Syndrome, Virus, Zoonosis

Comments (0)

Written by

Lakshmi Supriya

Lakshmi Supriya got her BSc in Industrial Chemistry from IIT Kharagpur (India) and a Ph.D. in Polymer Science and Engineering from Virginia Tech (USA).

Source: Read Full Article